Open AccessPD55-11 THE EFFECTS OF PLATINUM-BASED CHEMOTHERAPY RECHALLENGE FOR ADVANCED UROTHELIAL CARCINOMA PATIENTS WHOSE DISEASE PROGRESSED AFTER FIRST-LINE PLATINUM-BASED CHEMOTHERAPY AND PEMBROLIZUMAB
Author(s) -
Tetsuya Yumioka,
Masashi Honda,
Ryutaro Shimizu,
Shogo Teraoka,
Yusuke Kimura,
Hideto Iwamoto,
Shuichi Morizane,
Katsuya Hikita,
Atsushi Takenaka
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002089.11
Subject(s) - pembrolizumab , medicine , carboplatin , chemotherapy , regimen , docetaxel , gemcitabine , metastatic urothelial carcinoma , oncology , urothelial carcinoma , cancer , immunotherapy , bladder cancer , cisplatin